• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

处理健康相关生活质量纵向分析中的信息缺失:从食管癌临床试验 PRODIGE 5/ACCORD 17 数据中应用三种方法。

Handling informative dropout in longitudinal analysis of health-related quality of life: application of three approaches to data from the esophageal cancer clinical trial PRODIGE 5/ACCORD 17.

机构信息

Biometrics Unit, Montpellier Cancer Institute (ICM), University of Montpellier, 208, avenue des Apothicaires, 34298, Montpellier, France.

French National Platform Quality of Life and Cancer, Montpellier, France.

出版信息

BMC Med Res Methodol. 2020 Sep 3;20(1):223. doi: 10.1186/s12874-020-01104-w.

DOI:10.1186/s12874-020-01104-w
PMID:32883216
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7469318/
Abstract

BACKGROUND

Health-related quality of life (HRQoL) has become a major endpoint to assess the clinical benefit of new therapeutic strategies in oncology clinical trials. Typically, HRQoL outcomes are analyzed using linear mixed models (LMMs). However, longitudinal analysis of HRQoL in the presence of missing data remains complex and unstandardized. Our objective was to compare the modeling alternatives that account for informative dropout.

METHODS

We investigated three alternative methods-the selection model (SM), pattern-mixture model (PMM), and shared-parameters model (SPM)-in relation to the LMM. We first compared them on the basis of methodological arguments highlighting their advantages and drawbacks. Then, we applied them to data from a randomized clinical trial that included 267 patients with advanced esophageal cancer for the analysis of four HRQoL dimensions evaluated using the European Organisation for Research and Treatment of Cancer (EORTC) QLQ-C30 questionnaire.

RESULTS

We highlighted differences in terms of outputs, interpretation, and underlying modeling assumptions; this methodological comparison could guide the choice of method according to the context. In the application, none of the four models detected a significant difference between the two treatment arms. The estimated effect of time on HRQoL varied according to the method: for all analyzed dimensions, the PMM estimated an effect that contrasted with those estimated by the SM and SPM; the LMM estimated effects were confirmed by the SM (on two of four HRQoL dimensions) and SPM (on three of four HRQoL dimensions).

CONCLUSIONS

The PMM, SM, or SPM should be used to confirm or invalidate the results of LMM analysis when informative dropout is suspected. Of these three alternative methods, the SPM appears to be the most interesting from both theoretical and practical viewpoints.

TRIAL REGISTRATION

This study is registered with ClinicalTrials.gov , number NCT00861094 .

摘要

背景

健康相关生活质量(HRQoL)已成为评估肿瘤学临床试验中新治疗策略临床获益的主要终点。通常,使用线性混合模型(LMM)分析 HRQoL 结果。然而,在存在缺失数据的情况下,HRQoL 的纵向分析仍然复杂且未标准化。我们的目的是比较考虑信息性缺失的建模替代方案。

方法

我们研究了三种替代方法 - 选择模型(SM)、模式混合模型(PMM)和共享参数模型(SPM) - 与 LMM 相关。我们首先根据突出其优缺点的方法论点对它们进行比较。然后,我们将它们应用于一项随机临床试验的数据中,该试验纳入了 267 名晚期食管癌患者,使用欧洲癌症研究与治疗组织(EORTC)QLQ-C30 问卷评估了四个 HRQoL 维度。

结果

我们突出了输出、解释和潜在建模假设方面的差异;这种方法比较可以根据上下文指导方法的选择。在应用中,四种模型均未检测到两种治疗方法之间的显著差异。HRQoL 随时间的变化估计值因方法而异:对于所有分析的维度,PMM 估计的效果与 SM 和 SPM 估计的效果相反;LMM 的估计效果得到了 SM(四个 HRQoL 维度中的两个)和 SPM(四个 HRQoL 维度中的三个)的证实。

结论

当怀疑存在信息性缺失时,应使用 PMM、SM 或 SPM 来确认或否定 LMM 分析的结果。在这三种替代方法中,SPM 似乎从理论和实践角度来看都是最有趣的。

试验注册

这项研究在 ClinicalTrials.gov 注册,编号为 NCT00861094。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b797/7469318/653990aad82f/12874_2020_1104_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b797/7469318/8aabee81c0ef/12874_2020_1104_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b797/7469318/aa25cf4ef6c5/12874_2020_1104_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b797/7469318/f98c67cf89a9/12874_2020_1104_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b797/7469318/653990aad82f/12874_2020_1104_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b797/7469318/8aabee81c0ef/12874_2020_1104_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b797/7469318/aa25cf4ef6c5/12874_2020_1104_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b797/7469318/f98c67cf89a9/12874_2020_1104_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b797/7469318/653990aad82f/12874_2020_1104_Fig4_HTML.jpg

相似文献

1
Handling informative dropout in longitudinal analysis of health-related quality of life: application of three approaches to data from the esophageal cancer clinical trial PRODIGE 5/ACCORD 17.处理健康相关生活质量纵向分析中的信息缺失:从食管癌临床试验 PRODIGE 5/ACCORD 17 数据中应用三种方法。
BMC Med Res Methodol. 2020 Sep 3;20(1):223. doi: 10.1186/s12874-020-01104-w.
2
Flexible modeling of longitudinal health-related quality of life data accounting for informative dropout in a cancer clinical trial.灵活建模纵向健康相关生活质量数据,以考虑癌症临床试验中信息性缺失。
Qual Life Res. 2023 Mar;32(3):669-679. doi: 10.1007/s11136-022-03252-6. Epub 2022 Sep 17.
3
Joint modelling with competing risks of dropout for longitudinal analysis of health-related quality of life in cancer clinical trials.用于癌症临床试验中健康相关生活质量纵向分析的具有失访竞争风险的联合建模。
Qual Life Res. 2022 May;31(5):1359-1370. doi: 10.1007/s11136-021-03040-8. Epub 2021 Nov 24.
4
Applying the Longitudinal Model from Item Response Theory to Assess Health-Related Quality of Life in the PRODIGE 4/ACCORD 11 Randomized Trial.应用项目反应理论中的纵向模型评估PRODIGE 4/ACCORD 11随机试验中与健康相关的生活质量。
Med Decis Making. 2016 Jul;36(5):615-28. doi: 10.1177/0272989X15621883. Epub 2015 Dec 18.
5
Comparison of three longitudinal analysis models for the health-related quality of life in oncology: a simulation study.肿瘤学中三种纵向分析模型对健康相关生活质量的比较:一项模拟研究
Health Qual Life Outcomes. 2014 Dec 31;12:192. doi: 10.1186/s12955-014-0192-2.
6
Longitudinal analysis of health-related quality of life in cancer clinical trials: methods and interpretation of results.癌症临床试验中健康相关生活质量的纵向分析:方法和结果解读。
Qual Life Res. 2021 Jan;30(1):91-103. doi: 10.1007/s11136-020-02605-3. Epub 2020 Aug 18.
7
Longitudinal health-related quality of life analysis in oncology with time to event approaches, the STATA command qlqc30_TTD.时间依赖性事件方法在肿瘤学中的纵向健康相关生活质量分析,STATA 命令 qlqc30_TTD。
Comput Methods Programs Biomed. 2018 May;158:153-159. doi: 10.1016/j.cmpb.2018.02.010. Epub 2018 Feb 17.
8
Health-related quality of life in patients with microsatellite instability-high or mismatch repair deficient metastatic colorectal cancer treated with first-line pembrolizumab versus chemotherapy (KEYNOTE-177): an open-label, randomised, phase 3 trial.微卫星不稳定高或错配修复缺陷转移性结直肠癌患者一线帕博利珠单抗与化疗治疗的健康相关生活质量(KEYNOTE-177):一项开放标签、随机、III 期试验。
Lancet Oncol. 2021 May;22(5):665-677. doi: 10.1016/S1470-2045(21)00064-4. Epub 2021 Apr 1.
9
When a joint model should be preferred over a linear mixed model for analysis of longitudinal health-related quality of life data in cancer clinical trials.当需要分析癌症临床试验中与健康相关的纵向生活质量数据时,应优先选择联合模型而非线性混合模型。
BMC Med Res Methodol. 2023 Feb 10;23(1):36. doi: 10.1186/s12874-023-01846-3.
10
Reliability of an e-PRO Tool of EORTC QLQ-C30 for Measurement of Health-Related Quality of Life in Patients With Breast Cancer: Prospective Randomized Trial.欧洲癌症研究与治疗组织核心问卷(EORTC QLQ-C30)电子患者报告结局(e-PRO)工具用于测量乳腺癌患者健康相关生活质量的可靠性:前瞻性随机试验
J Med Internet Res. 2017 Sep 14;19(9):e322. doi: 10.2196/jmir.8210.

引用本文的文献

1
Banana Supplementation for Breast Cancer Surgery Patients: A Two-Center Experience.乳腺癌手术患者补充香蕉:一项双中心经验。
Breast Care (Basel). 2025 Mar 14:1-10. doi: 10.1159/000545174.
2
Analysis of Cohort Stepped Wedge Cluster-Randomized Trials With Nonignorable Dropout via Joint Modeling.通过联合建模对具有不可忽略失访的队列阶梯楔形整群随机试验进行分析。
Stat Med. 2025 Feb 28;44(5):e10347. doi: 10.1002/sim.10347.
3
When a joint model should be preferred over a linear mixed model for analysis of longitudinal health-related quality of life data in cancer clinical trials.

本文引用的文献

1
Moving forward toward standardizing analysis of quality of life data in randomized cancer clinical trials.朝着使癌症随机临床试验中生活质量数据分析标准化的方向前进。
Clin Trials. 2018 Dec;15(6):624-630. doi: 10.1177/1740774518795637. Epub 2018 Aug 24.
2
Health-related quality of life results from the PRODIGE 5/ACCORD 17 randomised trial of FOLFOX versus fluorouracil-cisplatin regimen in oesophageal cancer.PRODIGE 5/ACCORD 17食管癌FOLFOX与氟尿嘧啶-顺铂方案随机试验的健康相关生活质量结果。
Eur J Cancer. 2017 Oct;84:239-249. doi: 10.1016/j.ejca.2017.07.038. Epub 2017 Aug 19.
3
Reporting and dealing with missing quality of life data in RCTs: has the picture changed in the last decade?
当需要分析癌症临床试验中与健康相关的纵向生活质量数据时,应优先选择联合模型而非线性混合模型。
BMC Med Res Methodol. 2023 Feb 10;23(1):36. doi: 10.1186/s12874-023-01846-3.
报告与处理随机对照试验中缺失的生活质量数据:过去十年情况有变化吗?
Qual Life Res. 2016 Dec;25(12):2977-2983. doi: 10.1007/s11136-016-1411-6. Epub 2016 Sep 20.
4
Missing data in randomized controlled trials testing palliative interventions pose a significant risk of bias and loss of power: a systematic review and meta-analyses.测试姑息治疗干预措施的随机对照试验中的数据缺失会带来显著的偏倚风险和效能损失:一项系统评价与荟萃分析。
J Clin Epidemiol. 2016 Jun;74:57-65. doi: 10.1016/j.jclinepi.2015.12.003. Epub 2015 Dec 21.
5
Handling missing data in RCTs; a review of the top medical journals.随机对照试验中缺失数据的处理;顶级医学期刊综述
BMC Med Res Methodol. 2014 Nov 19;14:118. doi: 10.1186/1471-2288-14-118.
6
Definitive chemoradiotherapy with FOLFOX versus fluorouracil and cisplatin in patients with oesophageal cancer (PRODIGE5/ACCORD17): final results of a randomised, phase 2/3 trial.含奥沙利铂 FOLFOX 方案与氟尿嘧啶和顺铂方案在食管癌患者中的确证放化疗比较(PRODIGE5/ACCORD17):一项随机、2/3 期试验的最终结果。
Lancet Oncol. 2014 Mar;15(3):305-14. doi: 10.1016/S1470-2045(14)70028-2. Epub 2014 Feb 18.
7
Reporting of patient-reported outcomes in randomized trials: the CONSORT PRO extension.报告随机试验中患者报告结局的方法:CONSORT PRO 扩展。
JAMA. 2013 Feb 27;309(8):814-22. doi: 10.1001/jama.2013.879.
8
Practical and statistical issues in missing data for longitudinal patient-reported outcomes.纵向患者报告结局中缺失数据的实际问题与统计学问题
Stat Methods Med Res. 2014 Oct;23(5):440-59. doi: 10.1177/0962280213476378. Epub 2013 Feb 19.
9
The prevention and treatment of missing data in clinical trials.临床试验中缺失数据的预防与处理
N Engl J Med. 2012 Oct 4;367(14):1355-60. doi: 10.1056/NEJMsr1203730.
10
Health-related quality of life and cancer clinical trials.健康相关生活质量与癌症临床试验。
Ther Adv Med Oncol. 2011 Mar;3(2):57-71. doi: 10.1177/1758834010395342.